Results - Announcements
Kwality Pharmaceuticals Ltd share price softened by 1.09% to Rs 3942.2. The Company's net profit improved by 13.31% to Rs 29.03 crore, while revenue from operations edged up 11.62% to Rs 181.22 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, rising 6.40%. It has inched up 2.89% over last one week and ticked higher by 6.37% in last one month while the market capitalization of Kwality Pharmaceuticals Ltd has marginally improved by 8.15% and 14.44% in the same period respectively.
Profit before tax (PBT) of Kwality Pharmaceuticals Ltd stood at Rs 42.22 crore in Q2 FY27, expanding by 128.83% year-on-year, and jumping 24.21% quarter-on-quarter. EBITDA came in at Rs 49 crore, surging by 100.45% YoY and rallying 21.39% sequentially.
Total expenses grew marginally by 8.27% to Rs 136.78 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 81.68 crore, slightly declining by 4.29% YoY, while employee benefits expense was at Rs 18.81 crore, surging 27.61% YoY.
For FY26, revenue from operations jumped by 35.89% to Rs 503.08 crore, while net profit jumped 69.22% to Rs 67.35 crore, compared to previous FY. EBITDA soared by 7899% to Rs 115.38 crore, and PBT soared 65.29% to Rs 89.49 crore compared to previous FY.
The company's consolidated net cash flow from operating activities stood at Rs 16.59 crore in FY26, as against Rs 52.72 crore in FY25.
Kwality Pharmaceuticals Ltd surged by 347.39% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 3.03% during the same period.